rabbit polyclonal antibodies against hamster pcsk9 Search Results


93
Santa Cruz Biotechnology rabbit anti pcsk9 antibody
Rabbit Anti Pcsk9 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti pcsk9 antibody/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
rabbit anti pcsk9 antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

96
Proteintech rabbit monoclonal anti proprotein convertase subtilisin/kexin type 9 (pcsk9)
Rabbit Monoclonal Anti Proprotein Convertase Subtilisin/Kexin Type 9 (Pcsk9), supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit monoclonal anti proprotein convertase subtilisin/kexin type 9 (pcsk9)/product/Proteintech
Average 96 stars, based on 1 article reviews
rabbit monoclonal anti proprotein convertase subtilisin/kexin type 9 (pcsk9) - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

94
Proteintech pcsk9
Fig. 3 Effect of CM1 on the expression of lipid metabolism-related genes in the liver of LDLR(+/−) hamsters (n = 3). A, B, C, and D, mRNA expression of SREBP-2, <t>PCSK9,</t> LXRα, and SREBP-1c, respectively
Pcsk9, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcsk9/product/Proteintech
Average 94 stars, based on 1 article reviews
pcsk9 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
GenScript corporation rabbit anti-hamster pcsk9 antibody
Fig. 3 Effect of CM1 on the expression of lipid metabolism-related genes in the liver of LDLR(+/−) hamsters (n = 3). A, B, C, and D, mRNA expression of SREBP-2, <t>PCSK9,</t> LXRα, and SREBP-1c, respectively
Rabbit Anti Hamster Pcsk9 Antibody, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-hamster pcsk9 antibody/product/GenScript corporation
Average 90 stars, based on 1 article reviews
rabbit anti-hamster pcsk9 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Palo Alto Health Sciences rabbit anti-hamster pcsk9 polyclonal antibody
Fig. 3 Effect of CM1 on the expression of lipid metabolism-related genes in the liver of LDLR(+/−) hamsters (n = 3). A, B, C, and D, mRNA expression of SREBP-2, <t>PCSK9,</t> LXRα, and SREBP-1c, respectively
Rabbit Anti Hamster Pcsk9 Polyclonal Antibody, supplied by Palo Alto Health Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-hamster pcsk9 polyclonal antibody/product/Palo Alto Health Sciences
Average 90 stars, based on 1 article reviews
rabbit anti-hamster pcsk9 polyclonal antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Millipore monoclonal anti-β-actin
Fig. 3 Effect of CM1 on the expression of lipid metabolism-related genes in the liver of LDLR(+/−) hamsters (n = 3). A, B, C, and D, mRNA expression of SREBP-2, <t>PCSK9,</t> LXRα, and SREBP-1c, respectively
Monoclonal Anti β Actin, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal anti-β-actin/product/Millipore
Average 90 stars, based on 1 article reviews
monoclonal anti-β-actin - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

95
Proteintech apob
Fig. 3 Effect of CM1 on the expression of lipid metabolism-related genes in the liver of LDLR(+/−) hamsters (n = 3). A, B, C, and D, mRNA expression of SREBP-2, <t>PCSK9,</t> LXRα, and SREBP-1c, respectively
Apob, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apob/product/Proteintech
Average 95 stars, based on 1 article reviews
apob - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

96
Proteintech mouse calnexin primary
(A) SAR1B nitrosylates SURF4. FLAG-tagged SNO-SAR1B was incubated with V5-tagged SURF4. Reaction mixtures were subjected to SNO-RAC and SNO-proteins visualized by western blot. Representative image (n = 3) is shown. (B) SURF4 <t>nitrosylates</t> <t>PCSK9.</t> V5-tagged SNO-SURF4 was incubated with FLAG-tagged PCSK9. Reaction mixtures were subjected to SNO-RAC and SNO-proteins visualized by western blot. Representative image (n = 3) is shown. Mature PCSK9 is visualized in SNO-PCSK9 lanes. (C) Western blot analysis of SNO-PCSK9 and SNO-SAR1B in SCoR2-deficient HEK293 transfected with wild-type PCSK9 and wild-type SAR1B and treated with 200 μM ethyl ester S-nitroso-cysteine (ECySNO) for 90 min. Anti-FLAG antibody was used to visualize SAR1B. (D) Quantification (n = 3) of SNO-PCSK9 and SNO-SAR1B (normalized to total PCSK9 and SAR1B, respectively) from (C) and related experiments. (E) Western blot analysis of SNO-SAR1B wild-type and indicated mutations in SCoR2-deficient HEK293 transfected with SAR1B wild-type and indicated mutations and treated with 200 μM ECySNO for 90 min. Anti-FLAG antibody was used to visualize SAR1B in a single experiment that is verified in subsequent assays. (F) Western blot analysis of SNO-PCSK9, SNO-SURF4, and SNO-SAR1B in SCoR2-deficient HEK293 cells transiently overexpressing SAR1B WT or SAR1B C102A/C178A and treated with 200 μM ECySNO for 90 min prior to harvest. (G) Quantification (n = 3) of SNO-PCSK9 (mature band, normalized to total mature PCSK9) and SNO-SURF4 from (F). (H) Representative western blot analysis for cellular and secreted (media) PCSK9 in SCoR2-deficient HEK293 cells overexpressing SAR1B WT or SAR1B C102A/C178A and treated with 200 μM ECySNO for 90 min prior to harvest. (I) Quantification (n = 3) of secreted (media) PCSK9 (normalized to mature PCSK9 band) from (H). p values in (I) were calculated by one-way ANOVA. (J) SCoR-deficient HEK293 cells stably expressing PCSK9 were treated with or without 200 μM ECySNO (+SNO) for 90 min then stained with anti-PCSK9 (green) and <t>anti-calnexin</t> (red, ER marker) antibodies. Scale bar, 5 μm. (K) Quantification of mean PCSK9 signal intensity in pixels positive for calnexin (n = 12 cells per condition). Control: SNO-RAC assay performed without ascorbate. See also .
Mouse Calnexin Primary, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse calnexin primary/product/Proteintech
Average 96 stars, based on 1 article reviews
mouse calnexin primary - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

96
Proteintech albumin
(A) SAR1B nitrosylates SURF4. FLAG-tagged SNO-SAR1B was incubated with V5-tagged SURF4. Reaction mixtures were subjected to SNO-RAC and SNO-proteins visualized by western blot. Representative image (n = 3) is shown. (B) SURF4 <t>nitrosylates</t> <t>PCSK9.</t> V5-tagged SNO-SURF4 was incubated with FLAG-tagged PCSK9. Reaction mixtures were subjected to SNO-RAC and SNO-proteins visualized by western blot. Representative image (n = 3) is shown. Mature PCSK9 is visualized in SNO-PCSK9 lanes. (C) Western blot analysis of SNO-PCSK9 and SNO-SAR1B in SCoR2-deficient HEK293 transfected with wild-type PCSK9 and wild-type SAR1B and treated with 200 μM ethyl ester S-nitroso-cysteine (ECySNO) for 90 min. Anti-FLAG antibody was used to visualize SAR1B. (D) Quantification (n = 3) of SNO-PCSK9 and SNO-SAR1B (normalized to total PCSK9 and SAR1B, respectively) from (C) and related experiments. (E) Western blot analysis of SNO-SAR1B wild-type and indicated mutations in SCoR2-deficient HEK293 transfected with SAR1B wild-type and indicated mutations and treated with 200 μM ECySNO for 90 min. Anti-FLAG antibody was used to visualize SAR1B in a single experiment that is verified in subsequent assays. (F) Western blot analysis of SNO-PCSK9, SNO-SURF4, and SNO-SAR1B in SCoR2-deficient HEK293 cells transiently overexpressing SAR1B WT or SAR1B C102A/C178A and treated with 200 μM ECySNO for 90 min prior to harvest. (G) Quantification (n = 3) of SNO-PCSK9 (mature band, normalized to total mature PCSK9) and SNO-SURF4 from (F). (H) Representative western blot analysis for cellular and secreted (media) PCSK9 in SCoR2-deficient HEK293 cells overexpressing SAR1B WT or SAR1B C102A/C178A and treated with 200 μM ECySNO for 90 min prior to harvest. (I) Quantification (n = 3) of secreted (media) PCSK9 (normalized to mature PCSK9 band) from (H). p values in (I) were calculated by one-way ANOVA. (J) SCoR-deficient HEK293 cells stably expressing PCSK9 were treated with or without 200 μM ECySNO (+SNO) for 90 min then stained with anti-PCSK9 (green) and <t>anti-calnexin</t> (red, ER marker) antibodies. Scale bar, 5 μm. (K) Quantification of mean PCSK9 signal intensity in pixels positive for calnexin (n = 12 cells per condition). Control: SNO-RAC assay performed without ascorbate. See also .
Albumin, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/albumin/product/Proteintech
Average 96 stars, based on 1 article reviews
albumin - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

93
Proteintech cassette abc g5
(A) SAR1B nitrosylates SURF4. FLAG-tagged SNO-SAR1B was incubated with V5-tagged SURF4. Reaction mixtures were subjected to SNO-RAC and SNO-proteins visualized by western blot. Representative image (n = 3) is shown. (B) SURF4 <t>nitrosylates</t> <t>PCSK9.</t> V5-tagged SNO-SURF4 was incubated with FLAG-tagged PCSK9. Reaction mixtures were subjected to SNO-RAC and SNO-proteins visualized by western blot. Representative image (n = 3) is shown. Mature PCSK9 is visualized in SNO-PCSK9 lanes. (C) Western blot analysis of SNO-PCSK9 and SNO-SAR1B in SCoR2-deficient HEK293 transfected with wild-type PCSK9 and wild-type SAR1B and treated with 200 μM ethyl ester S-nitroso-cysteine (ECySNO) for 90 min. Anti-FLAG antibody was used to visualize SAR1B. (D) Quantification (n = 3) of SNO-PCSK9 and SNO-SAR1B (normalized to total PCSK9 and SAR1B, respectively) from (C) and related experiments. (E) Western blot analysis of SNO-SAR1B wild-type and indicated mutations in SCoR2-deficient HEK293 transfected with SAR1B wild-type and indicated mutations and treated with 200 μM ECySNO for 90 min. Anti-FLAG antibody was used to visualize SAR1B in a single experiment that is verified in subsequent assays. (F) Western blot analysis of SNO-PCSK9, SNO-SURF4, and SNO-SAR1B in SCoR2-deficient HEK293 cells transiently overexpressing SAR1B WT or SAR1B C102A/C178A and treated with 200 μM ECySNO for 90 min prior to harvest. (G) Quantification (n = 3) of SNO-PCSK9 (mature band, normalized to total mature PCSK9) and SNO-SURF4 from (F). (H) Representative western blot analysis for cellular and secreted (media) PCSK9 in SCoR2-deficient HEK293 cells overexpressing SAR1B WT or SAR1B C102A/C178A and treated with 200 μM ECySNO for 90 min prior to harvest. (I) Quantification (n = 3) of secreted (media) PCSK9 (normalized to mature PCSK9 band) from (H). p values in (I) were calculated by one-way ANOVA. (J) SCoR-deficient HEK293 cells stably expressing PCSK9 were treated with or without 200 μM ECySNO (+SNO) for 90 min then stained with anti-PCSK9 (green) and <t>anti-calnexin</t> (red, ER marker) antibodies. Scale bar, 5 μm. (K) Quantification of mean PCSK9 signal intensity in pixels positive for calnexin (n = 12 cells per condition). Control: SNO-RAC assay performed without ascorbate. See also .
Cassette Abc G5, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cassette abc g5/product/Proteintech
Average 93 stars, based on 1 article reviews
cassette abc g5 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


Fig. 3 Effect of CM1 on the expression of lipid metabolism-related genes in the liver of LDLR(+/−) hamsters (n = 3). A, B, C, and D, mRNA expression of SREBP-2, PCSK9, LXRα, and SREBP-1c, respectively

Journal: Lipids in health and disease

Article Title: Polysaccharide CM1 from Cordyceps militaris hinders adipocyte differentiation and alleviates hyperlipidemia in LDLR (+/-) hamsters.

doi: 10.1186/s12944-021-01606-6

Figure Lengend Snippet: Fig. 3 Effect of CM1 on the expression of lipid metabolism-related genes in the liver of LDLR(+/−) hamsters (n = 3). A, B, C, and D, mRNA expression of SREBP-2, PCSK9, LXRα, and SREBP-1c, respectively

Article Snippet: Rabbit polyclonal antibodies were used against PCSK9 (55206–1-AP), albumin (16475–1- AP), and apoB (20578–1-AP) (Proteintech, IL, USA).

Techniques: Expressing

Fig. 4 Effect of CM1 on the expression of TC metabolism-related proteins in the liver of the LDLR(+/−) hamsters (n = 5). A, SR-B1; B, LDLR; C, SREBP-2; D, PCSK9; E, CYP7A1; F, ABCG8; G, ABCG5; H, LXRα expression and densitometric quantification

Journal: Lipids in health and disease

Article Title: Polysaccharide CM1 from Cordyceps militaris hinders adipocyte differentiation and alleviates hyperlipidemia in LDLR (+/-) hamsters.

doi: 10.1186/s12944-021-01606-6

Figure Lengend Snippet: Fig. 4 Effect of CM1 on the expression of TC metabolism-related proteins in the liver of the LDLR(+/−) hamsters (n = 5). A, SR-B1; B, LDLR; C, SREBP-2; D, PCSK9; E, CYP7A1; F, ABCG8; G, ABCG5; H, LXRα expression and densitometric quantification

Article Snippet: Rabbit polyclonal antibodies were used against PCSK9 (55206–1-AP), albumin (16475–1- AP), and apoB (20578–1-AP) (Proteintech, IL, USA).

Techniques: Expressing

(A) SAR1B nitrosylates SURF4. FLAG-tagged SNO-SAR1B was incubated with V5-tagged SURF4. Reaction mixtures were subjected to SNO-RAC and SNO-proteins visualized by western blot. Representative image (n = 3) is shown. (B) SURF4 nitrosylates PCSK9. V5-tagged SNO-SURF4 was incubated with FLAG-tagged PCSK9. Reaction mixtures were subjected to SNO-RAC and SNO-proteins visualized by western blot. Representative image (n = 3) is shown. Mature PCSK9 is visualized in SNO-PCSK9 lanes. (C) Western blot analysis of SNO-PCSK9 and SNO-SAR1B in SCoR2-deficient HEK293 transfected with wild-type PCSK9 and wild-type SAR1B and treated with 200 μM ethyl ester S-nitroso-cysteine (ECySNO) for 90 min. Anti-FLAG antibody was used to visualize SAR1B. (D) Quantification (n = 3) of SNO-PCSK9 and SNO-SAR1B (normalized to total PCSK9 and SAR1B, respectively) from (C) and related experiments. (E) Western blot analysis of SNO-SAR1B wild-type and indicated mutations in SCoR2-deficient HEK293 transfected with SAR1B wild-type and indicated mutations and treated with 200 μM ECySNO for 90 min. Anti-FLAG antibody was used to visualize SAR1B in a single experiment that is verified in subsequent assays. (F) Western blot analysis of SNO-PCSK9, SNO-SURF4, and SNO-SAR1B in SCoR2-deficient HEK293 cells transiently overexpressing SAR1B WT or SAR1B C102A/C178A and treated with 200 μM ECySNO for 90 min prior to harvest. (G) Quantification (n = 3) of SNO-PCSK9 (mature band, normalized to total mature PCSK9) and SNO-SURF4 from (F). (H) Representative western blot analysis for cellular and secreted (media) PCSK9 in SCoR2-deficient HEK293 cells overexpressing SAR1B WT or SAR1B C102A/C178A and treated with 200 μM ECySNO for 90 min prior to harvest. (I) Quantification (n = 3) of secreted (media) PCSK9 (normalized to mature PCSK9 band) from (H). p values in (I) were calculated by one-way ANOVA. (J) SCoR-deficient HEK293 cells stably expressing PCSK9 were treated with or without 200 μM ECySNO (+SNO) for 90 min then stained with anti-PCSK9 (green) and anti-calnexin (red, ER marker) antibodies. Scale bar, 5 μm. (K) Quantification of mean PCSK9 signal intensity in pixels positive for calnexin (n = 12 cells per condition). Control: SNO-RAC assay performed without ascorbate. See also .

Journal: Cell reports

Article Title: A multienzyme S-nitrosylation cascade regulates cholesterol homeostasis

doi: 10.1016/j.celrep.2022.111538

Figure Lengend Snippet: (A) SAR1B nitrosylates SURF4. FLAG-tagged SNO-SAR1B was incubated with V5-tagged SURF4. Reaction mixtures were subjected to SNO-RAC and SNO-proteins visualized by western blot. Representative image (n = 3) is shown. (B) SURF4 nitrosylates PCSK9. V5-tagged SNO-SURF4 was incubated with FLAG-tagged PCSK9. Reaction mixtures were subjected to SNO-RAC and SNO-proteins visualized by western blot. Representative image (n = 3) is shown. Mature PCSK9 is visualized in SNO-PCSK9 lanes. (C) Western blot analysis of SNO-PCSK9 and SNO-SAR1B in SCoR2-deficient HEK293 transfected with wild-type PCSK9 and wild-type SAR1B and treated with 200 μM ethyl ester S-nitroso-cysteine (ECySNO) for 90 min. Anti-FLAG antibody was used to visualize SAR1B. (D) Quantification (n = 3) of SNO-PCSK9 and SNO-SAR1B (normalized to total PCSK9 and SAR1B, respectively) from (C) and related experiments. (E) Western blot analysis of SNO-SAR1B wild-type and indicated mutations in SCoR2-deficient HEK293 transfected with SAR1B wild-type and indicated mutations and treated with 200 μM ECySNO for 90 min. Anti-FLAG antibody was used to visualize SAR1B in a single experiment that is verified in subsequent assays. (F) Western blot analysis of SNO-PCSK9, SNO-SURF4, and SNO-SAR1B in SCoR2-deficient HEK293 cells transiently overexpressing SAR1B WT or SAR1B C102A/C178A and treated with 200 μM ECySNO for 90 min prior to harvest. (G) Quantification (n = 3) of SNO-PCSK9 (mature band, normalized to total mature PCSK9) and SNO-SURF4 from (F). (H) Representative western blot analysis for cellular and secreted (media) PCSK9 in SCoR2-deficient HEK293 cells overexpressing SAR1B WT or SAR1B C102A/C178A and treated with 200 μM ECySNO for 90 min prior to harvest. (I) Quantification (n = 3) of secreted (media) PCSK9 (normalized to mature PCSK9 band) from (H). p values in (I) were calculated by one-way ANOVA. (J) SCoR-deficient HEK293 cells stably expressing PCSK9 were treated with or without 200 μM ECySNO (+SNO) for 90 min then stained with anti-PCSK9 (green) and anti-calnexin (red, ER marker) antibodies. Scale bar, 5 μm. (K) Quantification of mean PCSK9 signal intensity in pixels positive for calnexin (n = 12 cells per condition). Control: SNO-RAC assay performed without ascorbate. See also .

Article Snippet: For PCSK9 visualization experiments, cells were stained with rabbit PCSK9 primary (Proteintech) and mouse Calnexin primary then stained with Alexa488-conjugated anti-rabbit and Alexa594-conjugated anti-mouse secondary antibodies.

Techniques: Incubation, Western Blot, Transfection, Stable Transfection, Expressing, Staining, Marker, Control

Journal: Cell reports

Article Title: A multienzyme S-nitrosylation cascade regulates cholesterol homeostasis

doi: 10.1016/j.celrep.2022.111538

Figure Lengend Snippet:

Article Snippet: For PCSK9 visualization experiments, cells were stained with rabbit PCSK9 primary (Proteintech) and mouse Calnexin primary then stained with Alexa488-conjugated anti-rabbit and Alexa594-conjugated anti-mouse secondary antibodies.

Techniques: Recombinant, Cholesterol Assay, Enzyme-linked Immunosorbent Assay, Stable Transfection, Expressing, shRNA, Mutagenesis, Software